Display Settings:

Format

Send to:

Choose Destination
Ann Rheum Dis. 1988 Aug;47(8):654-9.

Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations.

Author information

  • 1Department of Rheumatology, Ichilov Hospital, Tel Aviv, Israel.

Abstract

In a prospective open study 44 Israeli patients with rheumatoid arthritis were treated with weekly low dose methotrexate (MTX) for up to 36 months. Nine patients withdrew from the study: six because of side effects and three due to inefficacy. One patient died of septicaemia following septic arthritis. Significant improvement, graded by Ritchie articular index, grip strength, physician's global assessment, erythrocyte sedimentation rate (ESR), and platelet counts, was noticed in response to treatment. Seronegative patients had a better clinical response. Transient gastrointestinal symptoms were common and correlated with increases of serum aspartate transaminase (AST). HLA-DR1 and DR7 were significantly associated with increased serum AST concentrations.

PMID:
3415364
[PubMed - indexed for MEDLINE]
PMCID:
PMC1006717
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk